HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.

Abstract
Heterologous priming and boosting with antigens expressed by DNA, viral vectors, or as proteins, are experimental strategies to induce strong immune responses against infectious diseases and cancer. In a preclinical study we compared the ability of recombinant modified vaccinia Ankara encoding HIV antigens (MVA-CMDR), and/or recombinant gp140C (rgp140C), to boost responses induced by a multigene/multisubtype HIV DNA vaccine delivered by electroporation (EP). Homologous DNA immunizations augmented by EP stimulated strong cellular immune responses. Still stronger cellular immune responses were observed after DNA priming and MVA-CMDR boosting, which was superior to all other immunization schedules tested in terms of antigen-specific IFN-γ, IL-2, and bifunctional IFN-γ and IL-2 responses. For HIV Env-specific antibody responses, mice receiving repeated rgp140C immunizations, and mice boosted with rgp140C, elicited the highest binding titers and the highest numbers of antibody-secreting B cells. When considering both cellular and humoral immune responses, a combination of DNA, MVA-CMDR, and rgp140C immunizations induced the overall most potent immune responses and the highest avidity of HIV Env-specific antibodies. These data emphasize the importance of including multiple vaccine modalities that can stimulate both T and B cells, and thus elicit strong and balanced immune responses. The present HIV vaccine combination holds promise for further evaluation in clinical trials.
AuthorsDavid Hallengärd, Steven E Applequist, Sanna Nyström, Anna-Karin Maltais, Mary Marovich, Bernard Moss, Patricia Earl, Kopek Nihlmark, Britta Wahren, Andreas Bråve
JournalViral immunology (Viral Immunol) Vol. 25 Issue 5 Pg. 423-32 (Oct 2012) ISSN: 1557-8976 [Electronic] United States
PMID23035853 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AIDS Vaccines
  • DNA, Viral
  • HIV Antibodies
  • Interleukin-2
  • Vaccines, DNA
  • Vaccines, Synthetic
  • Interferon-gamma
Topics
  • AIDS Vaccines (administration & dosage, immunology)
  • Animals
  • DNA, Viral (immunology)
  • Female
  • HIV (genetics, immunology)
  • HIV Antibodies (blood, immunology)
  • HIV Infections (immunology, prevention & control)
  • Immunization, Secondary
  • Interferon-gamma (blood)
  • Interleukin-2 (blood)
  • Mice
  • Mice, Inbred BALB C
  • Vaccination
  • Vaccines, DNA (administration & dosage, genetics, immunology)
  • Vaccines, Synthetic (administration & dosage, genetics, immunology)
  • Vaccinia virus (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: